NUCB2
Nucleobindin-2
Also known as: NEFA, NUCB2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P80303
- Gene
- NUCB2
- Ensembl
- ENSG00000070081
- Chromosome
- 11
- Canonical length
- 420 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a protein with a suggested role in calcium level maintenance, eating regulation in the hypothalamus, and release of tumor necrosis factor from vascular endothelial cells. This protein binds calcium and has EF-folding domains. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
420 residues, UniProt reviewed canonical sequence.
>P80303|NUCB2
1 MRWRTILLQY CFLLITCLLT ALEAVPIDID KTKVQNIHPV ESAKIEPPDT GLYYDEYLKQ
61 VIDVLETDKH FREKLQKADI EEIKSGRLSK ELDLVSHHVR TKLDELKRQE VGRLRMLIKA
121 KLDSLQDIGM DHQALLKQFD HLNHLNPDKF ESTDLDMLIK AATSDLEHYD KTRHEEFKKY
181 EMMKEHERRE YLKTLNEEKR KEEESKFEEM KKKHENHPKV NHPGSKDQLK EVWEETDGLD
241 PNDFDPKTFF KLHDVNSDGF LDEQELEALF TKELEKVYDP KNEEDDMVEM EEERLRMREH
301 VMNEVDTNKD RLVTLEEFLK ATEKKEFLEP DSWETLDQQQ FFTEEELKEY ENIIALQENE
361 LKKKADELQK QKEELQRQHD QLEAQKLEYH QVIQQMEQKK LQQGIPPSGP AGELKFEPHILocalizationUniProt · AlphaFold · HPA
Whether an antibody against NUCB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 478 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 478 nTPM
- pancreas: 466 nTPM
- bone marrow: 373 nTPM
- parathyroid gland: 291 nTPM
- epididymis: 253 nTPM
- thymus: 225 nTPM
Single-cell type
- esophageal apical cells: 3,055 nCPM
- syncytiotrophoblasts: 1,906 nCPM
- epididymal principal cells: 1,534 nCPM
- conjunctival goblet cells: 909 nCPM
- salivary acinar cells: 885 nCPM
- respiratory deuterosomal cells: 824 nCPM
Immune cell
- plasmacytoid DC: 378 nTPM
- NK-cell: 237 nTPM
- naive CD8 T-cell: 232 nTPM
- naive CD4 T-cell: 213 nTPM
- basophil: 184 nTPM
- memory CD8 T-cell: 140 nTPM
Brain region
- choroid plexus: 78 nTPM
- hypothalamus: 48 nTPM
- cerebellum: 37 nTPM
- midbrain: 37 nTPM
- basal ganglia: 36 nTPM
- white matter: 35 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NUCB2.
Disease | ImmuneIEDB
Conditions an epitope on NUCB2 was assayed in.
- type 1 diabetes mellitus T cell
ReferencesPubMed · IEDB
Publications for NUCB2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Molecular characterisation and expression analysis of SEREX-defined antigen NUCB2 in gastric epithelium, gastritis and gastric cancer.
2009 · Eur J Histochem · RCR 0.6 · 19 citations - Molecular characterisation and expression analysis of SEREX-defined antigen NUCB2 in gastric epithelium, gastritis and gastric cancer.
2009 · Eur J Histochem · RCR 0.4 · 14 citations
Reference: T cellIEDB
1 publication
- The antigen presentation landscape of cytokine-stressed human pancreatic islets.
2025 · Cell Rep · RCR 2.5 · 8 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.9
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- calcium ion binding
- DNA binding
- G-protein alpha-subunit binding
- guanyl-nucleotide exchange factor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NUCB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NUCB2 as an antibody target. Whether an autoantibody or antibody against NUCB2 could matter depends on whether native NUCB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NUCB2 is annotated as secreted, so native NUCB2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label NUCB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...